Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-26

Clinical Trial Update: Nucleo CMP and Neurorubine Versus Carbamazepine for Classical Trigeminal Neuralgia [Phase 2]

View source ↗

Summary

Phase 2 trial comparing Nucleo CMP and Neurorubine against Carbamazepine for classical trigeminal neuralgia has completed; no outcome results are provided in th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbamazepine (Carbamazepine)
  • Neurorubine
  • Nucleo CMP

Snippet

Sponsor: Karbala University | Conditions: Trigeminal Neuralgia, Neuropathic Pain | Phase 2 | Status: COMPLETED